S&P 500 cuts losses as Nvidia climbs ahead of results
Airsculpt Technologies, Inc. (AIRS) has experienced a significant downturn, with its stock price reaching a 52-week low of $1.65. The company’s financial health score from InvestingPro is rated as "FAIR," with a concerning current ratio of 0.6 indicating potential liquidity challenges. This latest price level reflects a stark contrast to the company’s performance over the past year, which has seen the stock plummet by approximately 68%. With revenue declining by 8% and three analysts recently revising earnings downward, investors have been closely monitoring Airsculpt Technologies as it navigates through market challenges. The current low represents a critical juncture for the company’s valuation and future prospects, with InvestingPro analysis suggesting the stock is currently undervalued. The 52-week low serves as a key indicator for potential investors and market analysts who are assessing the company’s health and potential for recovery. Discover comprehensive valuation metrics and 12 additional exclusive ProTips with an InvestingPro subscription.
In other recent news, AirSculpt Technologies reported fourth-quarter earnings that fell short of analyst expectations. The company posted an adjusted loss of $0.09 per share, missing the anticipated $0.02 earnings per share. Revenue for the quarter was $39.2 million, below the consensus forecast of $44.4 million and down 17.7% from the previous year. Additionally, case volume declined by 16.7% to 3,064 procedures compared to the same quarter last year. AirSculpt also reported a net loss of $5.0 million for the quarter, which was wider than the $4.6 million loss in the same period of 2023. For the full year 2024, the company saw a revenue decrease of 7.9% to $180.4 million, with case volume dropping by 6% to 14,036 procedures. CEO Yogi Jashnani has announced plans to stabilize same-center sales through improved marketing, sales strategies, and expanded consumer financing options. The company has also implemented a cost reduction program projected to save $3 million annually.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.